Lori Lyons-Williams
Director/Board Member at CONTINEUM THERAPEUTICS, INC.
Net worth: - $ as of 2024-05-30
Profile
Lori M.
Lyons-Williams is currently the President & Chief Executive Officer at Abdera Therapeutics, Inc. She is also the Vice Chairman at the National Association for Continence.
In addition, she serves as an Independent Director at Rapt Therapeutics, Inc. and as a Director at Contineum Therapeutics, Inc. Previously, Ms. Lyons-Williams held positions as an Independent Director at Five Prime Therapeutics, Inc. from 2019 to 2021.
She also served as a Director at Girls, Inc. and as the Chief Operating Officer at Neumora Therapeutics, Inc. from 2020 to 2023.
Prior to that, she was the Chief Commercial Officer at Dermira, Inc. from 2016 to 2020, and the Vice President-Sales & Marketing at Allergan, Inc. from 2002 to 2016.
Ms. Lyons-Williams obtained her undergraduate degree from Virginia Polytechnic Institute & State University.
She also holds an MBA from The Curtis L.
Carlson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RAPT THERAPEUTICS, INC.
-.--% | 2024-05-21 | 0 ( -.--% ) | - $ | 2024-05-30 |
| 2024-05-23 | 0 ( -.--% ) | - $ | 2024-05-30 |
Lori Lyons-Williams active positions
| Companies | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Director/Board Member | 2020-07-31 |
| RAPT THERAPEUTICS, INC. | Director/Board Member | 2021-11-08 |
National Association for Continence
 National Association for Continence Miscellaneous Commercial ServicesCommercial Services National Association for Continence is a non profit organization provides healthcare services. It offers public education and advocacy about the causes, prevention, diagnosis, treatments, and management alternatives for incontinence. The company was founded by Katherine F. Jeter in September 1982 and is headquartered in Philadelphia, PA | Director/Board Member | - |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Chief Executive Officer | 2022-04-30 |
Former positions of Lori Lyons-Williams
| Companies | Position | End |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | President | 2019-12-31 |
| FIVE PRIME THERAPEUTICS, INC. | Director/Board Member | 2021-04-15 |
| DERMIRA, INC. | Corporate Officer/Principal | 2019-12-31 |
| ALLERGAN, INC. | Sales & Marketing | 2016-07-31 |
Girls, Inc.
 Girls, Inc. Miscellaneous Commercial ServicesCommercial Services Girls, Inc. provides educational programs for girls. It offers healthy living, academic enrichment and support and life skill instruction. The company was founded in 1864 and is headquartered in New York, NY. | Director/Board Member | - |
Training of Lori Lyons-Williams
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
| The Curtis L. Carlson School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
National Association for Continence
National Association for Continence Miscellaneous Commercial ServicesCommercial Services National Association for Continence is a non profit organization provides healthcare services. It offers public education and advocacy about the causes, prevention, diagnosis, treatments, and management alternatives for incontinence. The company was founded by Katherine F. Jeter in September 1982 and is headquartered in Philadelphia, PA | Commercial Services |
Girls, Inc.
Girls, Inc. Miscellaneous Commercial ServicesCommercial Services Girls, Inc. provides educational programs for girls. It offers healthy living, academic enrichment and support and life skill instruction. The company was founded in 1864 and is headquartered in New York, NY. | Commercial Services |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Health Technology |
- Stock Market
- Insiders
- Lori Lyons-Williams
